… breast cancer. Although clinical trials in breast cancer … tumor microenvironment for breast tumor-bearing mice. Sci … quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology … in treatment of breast cancer. Breast Cancer. 2022;16: …

… HER2 positive breast cancer. Enhertu is … breast cancer, later-line HER2 positive metastatic breast cancer, later-line HER2 low metastatic breast cancer … taxane [docetaxel or paclitaxel], trastuzumab and pertuzumab … positive metastatic breast cancer is an …

… drug conjugates (ADCs) for breast cancer presents both significant opportunities … considerations for integrating ADCs into breast cancer treatment paradigms, emphasizing the … anthracyclines with cyclophosphamide, carboplatin with paclitaxel, et cetera. It’s …

… Trastuzumab, Paclitaxel, Gemcitabine/Carboplatin, Iniparib , and others. Breast Cancer Therapeutic … Breast Cancer Executive Summary Breast Cancer: Overview Breast Cancer Pipeline Therapeutics Breast Cancer Therapeutic Assessment Breast Cancer– …

… treatment of metastatic triple-negative breast cancer with PD-L1 positivity, [which … anthracyclines with cyclophosphamide, carboplatin with paclitaxel, etc. It’s a brave … –positive (HER2+) advanced/metastatic breast cancer (a/mBC): interim results …

… Abbreviations: TNBC, triple-negative breast cancer; NAC, neoadjuvant chemotherapy; pCR … ) or twelve cycles of paclitaxel (80mg/m2). … markers in triple-negative breast cancer. Breast Cancer. 2023;30(6): … and survival in breast cancer patients treated with …

… treating paclitaxel-induced peripheral neuropathy in breast cancer patients … psychological distress in breast cancer patients suffering from … However, for advanced breast cancer patients undergoing continuous … peripheral neuropathy in breast cancer survivors: a …

… to III HER2-positive breast cancer, outperforming HR status … HER2-positive (ERBB2+) breast cancer at Catalan Institute … before the initiation of paclitaxel. Following neoadjuvant therapy … positive breast cancer treated with 15 weeks of neoadjuvant paclitaxel, …

… complete response (pCR) in breast cancer patients undergoing neoadjuvant chemotherapy. … 5); and doxorubicin, cyclophosphamide, and paclitaxel (n = 1). Following therapy, … composition and pCR in breast cancer patients undergoing neoadjuvant chemotherapy. …

… new treatment for triple-negative breast cancer (TNBC) that tackles … chemotherapy drugs such as paclitaxel and currently cannot be … it often becomes resistant to paclitaxel, causing the survival rate … when used in combination with paclitaxel, he added. The …